The Board's opinion on significant events and set-off

The Board's opinion on significant events and set-off in PDF
(In Swedish)

About Bluefish Pharmaceuticals
Bluefish has undergone significant international expansion since the company was founded in 2005. Bluefish focuses on the development, manufacture and sale of generic pharmaceuticals. The company conducts marketing operations in a large number of European markets and is expanding into territories outside Europe. The product portfolio consists of a total of approximately 80 products and is growing.

www.bluefishpharma.com

The Board's opinion on significant events and set-off (Swedish)